日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Development of a novel BRCAness score that predicts response to PARP inhibitors

开发一种预测 PARP 抑制剂疗效的新型 BRCAness 评分

期刊:Biomarker Research
影响因子:11.5
doi:10.1186/s40364-022-00427-8
Oshi, Masanori; Gandhi, Shipra; Wu, Rongrong; Asaoka, Mariko; Yan, Li; Yamada, Akimitsu; Yamamoto, Shinya; Narui, Kazutaka; Chishima, Takashi; Ishikawa, Takashi; Endo, Itaru; Takabe, Kazuaki
PARP
发表日期：2022
文献解析 文献求助 收藏

Breast cancer risk assessment based on a predictive model: evaluation of risk factors among Japanese women

基于预测模型的乳腺癌风险评估：日本女性风险因素评价

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13556-8
Yamada, Michiyo; Chishima, Takashi; Ishikawa, Takashi; Narui, Kazutaka; Sugae, Sadatoshi; Tonellato, Peter J; Endo, Itaru
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Clinicopathological Characteristics and Prognosis of Triple-Negative Apocrine Carcinoma: A Case-Control Study

三阴性顶泌癌的临床病理特征及预后：一项病例对照研究

期刊:World Journal of Oncology
影响因子:2.2
doi:10.14740/wjon1694
Suzuki, Chiho; Yamada, Akimitsu; Kawashima, Kei; Sasamoto, Mahato; Fujiwara, Yoshie; Adachi, Shoko; Oshi, Masanori; Wada, Tomoko; Yamamoto, Shinya; Shimada, Kazuhiro; Ota, Ikuko; Narui, Kazutaka; Sugae, Sadatoshi; Shimizu, Daisuke; Tanabe, Mikiko; Chishima, Takashi; Ichikawa, Yasushi; Ishikawa, Takashi; Endo, Itaru
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Stratification of Prognosis by Biological Features Following Neoadjuvant Chemotherapy in Luminal Breast Cancer

根据生物学特征对管腔型乳腺癌新辅助化疗后的预后进行分层

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.12774
Yamamoto, Shinya; Chishima, Takashi; Shibata, Yukako; Inoue, Shiori; Harada, Fumi; Takeuchi, Hideki; Yamada, Akimitsu; Narui, Kazutaka; Endo, Itaru
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

A case of matrix-producing carcinoma of the breast treated with preoperative chemotherapy

一例采用术前化疗治疗的乳腺基质生成癌病例

期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-22-179
Kimura, Aki; Yamada, Akimitsu; Shibata, Yukako; Inoue, Shiori; Oshi, Masanori; Harada, Fumi; Kadokura, Toshiaki; Takeuchi, Hideki; Hasegawa, Naoki; Kakuta, Yukio; Endo, Itaru; Chishima, Takashi
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer

新型乳腺癌Oncotype DX复发评分预测模型的临床意义

期刊:In Vivo
影响因子:1.8
doi:10.21873/invivo.12522
Yamamoto, Shinya; Chishima, Takashi; Shibata, Yukako; Harada, Fumi; Takeuchi, Hideki; Yamada, Akimitsu; Narui, Kazutaka; Misumi, Toshihiro; Ishikawa, Takashi; Endo, Itaru
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Patient-derived orthotopic xenograft models for cancer of unknown primary precisely distinguish chemotherapy, and tumor-targeting S. typhimurium A1-R is superior to first-line chemotherapy

患者来源的原位异种移植模型能够精确区分化疗方案和靶向肿瘤的鼠伤寒沙门氏菌A1-R方案，且该方案优于一线化疗方案。

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-018-0016-7
Miyake, Kentaro; Kiyuna, Tasuku; Miyake, Masuyo; Kawaguchi, Kei; Yoon, Sang Nam; Zhang, Zhiying; Igarashi, Kentaro; Razmjooei, Sahar; Wangsiricharoen, Sintawat; Murakami, Takashi; Li, Yunfeng; Nelson, Scott D; Russell, Tara A; Singh, Arun S; Hiroshima, Yukihiko; Momiyama, Masashi; Matsuyama, Ryusei; Chishima, Takashi; Singh, Shree Ram; Endo, Itaru; Eilber, Fritz C; Hoffman, Robert M
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏

Tumor-targeting Salmonella typhimurium A1-R suppressed an imatinib-resistant gastrointestinal stromal tumor with c-kit exon 11 and 17 mutations

靶向肿瘤的鼠伤寒沙门氏菌A1-R抑制了具有c-kit外显子11和17突变的伊马替尼耐药性胃肠道间质瘤

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2018.e00643
Miyake, Kentaro; Kawaguchi, Kei; Miyake, Masuyo; Zhao, Ming; Kiyuna, Tasuku; Igarashi, Kentaro; Zhang, Zhiying; Murakami, Takashi; Li, Yunfeng; Nelson, Scott D; Bouvet, Michael; Elliott, Irmina; Russell, Tara A; Singh, Arun S; Hiroshima, Yukihiko; Momiyama, Masashi; Matsuyama, Ryusei; Chishima, Takashi; Singh, Shree Ram; Endo, Itaru; Eilber, Fritz C; Hoffman, Robert M
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏

Regorafenib regresses an imatinib-resistant recurrent gastrointestinal stromal tumor (GIST) with a mutation in exons 11 and 17 of c-kit in a patient-derived orthotopic xenograft (PDOX) nude mouse model

在患者来源的原位异种移植（PDOX）裸鼠模型中，瑞戈非尼可使携带c-kit基因11和17号外显子突变的伊马替尼耐药复发性胃肠道间质瘤（GIST）消退。

期刊:Cell Cycle
影响因子:3.4
doi:10.1080/15384101.2017.1423223
Miyake, Kentaro; Kawaguchi, Kei; Kiyuna, Tasuku; Miyake, Masuyo; Igarashi, Kentaro; Zhang, Zhiying; Murakami, Takashi; Li, Yunfeng; Nelson, Scott D; Elliott, Irmina; Russell, Tara; Singh, Arun; Hiroshima, Yukihiko; Momiyama, Masashi; Matsuyama, Ryusei; Chishima, Takashi; Endo, Itaru; Eilber, Fritz C; Hoffman, Robert M
发表日期：2018
文献求助 收藏

The irony of highly-effective bacterial therapy of a patient-derived orthotopic xenograft (PDOX) model of Ewing's sarcoma, which was blocked by Ewing himself 80 years ago

讽刺的是，一种针对尤文氏肉瘤患者来源的原位异种移植（PDOX）模型的高效细菌疗法，却在80年前被尤文本人所阻挠。

期刊:Cell Cycle
影响因子:3.4
doi:10.1080/15384101.2017.1304340
Murakami, Takashi; Kiyuna, Tasuku; Kawaguchi, Kei; Igarashi, Kentaro; Singh, Arun S; Hiroshima, Yukihiko; Zhang, Yong; Zhao, Ming; Miyake, Kentaro; Nelson, Scott D; Dry, Sarah M; Li, Yunfeng; DeLong, Jonathan C; Lwin, Thinzar M; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Eilber, Fritz C; Hoffman, Robert M
微生物学
发表日期：2017
文献求助 收藏